Schriftgut

Imurek 25 (The Wellcome Foundation Limited)

to related objects

Enthält:
Aus der Zulassungsakte entnommene Unterlagen (ungültige Vorschriften)

Reference number: Bundesarchiv, BArch DQ 116/2087

Former reference number: Aktenzeichen: 00/09/15

Language of the material: deutsch

Context: Institut für Arzneimittelwesen (IFAR) der DDR >> DQ 116 Institut für Arzneimittelwesen (IFAR) der DDR >> Zulassung von im Ausland hergestellten Arzneimitteln in der DDR (Importe) >> Großbritannien (00/09)

Holding: BArch DQ 116 Institut für Arzneimittelwesen (IFAR) der DDR

Date of creation: 1990 (1996)

Other object pages: Show object in "Archivportal-D"

Provenance: Institut für Arzneimittelwesen der DDR (IFAR), 1974-1990

Last update: 30.01.2024, 2:42 PM CET

Data provider

This object is provided by:
Bundesarchiv. If you have any questions about the object, please contact the data provider.

Show original at data provider

Object type

Schriftgut

Time of origin

1990 (1996)

Other Objects (12)

Schriftgut

Zyloric/Allopurinol (The Wellcome Foundation Limited)

Schriftgut

Tubarine miscible (The Wellcome Foundation Limited)

Schriftgut

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg

Schriftgut

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 4

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 2

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 3

Schriftgut

Zyloric/Allopurinol (The Wellcome Foundation Limited)

Schriftgut

Tubarine miscible (The Wellcome Foundation Limited)

Schriftgut

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg

Schriftgut

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 4

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 2

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 3

Schriftgut

Zyloric/Allopurinol (The Wellcome Foundation Limited)

Schriftgut

Tubarine miscible (The Wellcome Foundation Limited)

Schriftgut

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg

Schriftgut

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 4

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 1

Schriftgut

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 2

Schriftgut

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3

Schriftgut

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 3

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Imurek 25 (The Wellcome Foundation Limited)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Object type

Time of origin

Other Objects (12)

Zyloric/Allopurinol (The Wellcome Foundation Limited)

Tubarine miscible (The Wellcome Foundation Limited)

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 4

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 1

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 1

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 2

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 3

Zyloric/Allopurinol (The Wellcome Foundation Limited)

Tubarine miscible (The Wellcome Foundation Limited)

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 4

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 1

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 1

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 2

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 3

Zyloric/Allopurinol (The Wellcome Foundation Limited)

Tubarine miscible (The Wellcome Foundation Limited)

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg

Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 4

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 1

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 1

Myleran/Busulfan-Tabletten 2 mg (The Wellcome Foundation Limited): Bd. 2

Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3

Lanvis/Thioguanin-Tabletten 40 mg (The Wellcome Foundation Limited): Bd. 3

Related objects

Reset password